drugset / Trial / NCT01664143
A Single-Center Study of RO5508887 in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
This single-center, randomized, double-blind, placebo-controlled study will evaluate the safety, pharmacokinetics and pharmacodynamics of RO5508887 in healthy volunteers. Volunteers will receive multiple-ascending doses of RO5508887 or matching placebo. The anticipated time on study treatment is 14 days.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO5508887 | Unknown | — | Oral |
Indications
No indication recorded.